About Us

Entac Medical is a digital health company developing wearable devices applying predictive analytics/AI to biological acoustic signals to predict downstream patient adverse events.

Our purpose is to provide proactive risk mitigation of AE’s, improved patient compliance through continuous monitoring, and prevent hospital readmissions.

Leadership Team

Buddy Lyons

CEO

  • 25 years’ experience in healthcare investing and startup operations
  • Founder and CEO/COO of three predictive analytic/AI technologies in various stages of commercialization, including:
    • Audio spectral analysis for PrevisEA and PrevisAIplatform
    • Limited lead device for mass screening and prediction of delirium (encephalopathy)
    • Machine learning platform that consumes EHR data for predicting downstream adverse events in hospitalized patients at the point-of-care

Andrew Forsdick

CFO

  • Founder and Partner in Sage Business Advisors, a management company that works with early stage and startup companies to fill C-suite positions on an outsourced basis
  • Founder and Partner in Sage Advantage Fund, a venture capital fund with a large concentration in healthcare companies
  • Serves as CFO and financial strategist for multiple Sage and healthcare companies
  • Founder of multiple companies
  • Assisted in capital formation of multiple companies

John Cromwell, MD FACS FASCRS

CMO/CTO

  • Clinical Professor of Surgery; Director of GI, Minimally Invasive and Bariatric Surgery; Associate Chief Medical Officer; and Director of Surgical Quality and Safety; all at the University of Iowa Hospitals and Clinics
  • Authority on predictive analytics and applied AI/machine learning
  • Inventor of three predictive analytic/AI technologies in various stages of commercialization, including:
    • Audio spectral analysis for PrevisEA and PrevisAIplatform
    • Limited lead device for mass screening and prediction of delirium (encephalopathy)
    • Machine learning platform that consumes EHR data for predicting downstream adverse events in hospitalized patients at the point-of-care